A new mouse model called YG8-800, which accurately captures key features of Friedreich’s ataxia such as neurological dysfunction and…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
The Friedreich’s ataxia community wants to get people talking about ataxia — a group of disorders that affect co-ordination,…
Skin cells of people with Friedreich’s ataxia (FA) show dysregulated levels of fat molecules, including abnormal levels of a…
Note: This story was updated on Aug. 10, 2022, to add the U.S. Food and Drug Administration has extended…
Mutations that cause Friedreich’s ataxia lead to abnormalities in how nerve fibers grow and reduce their ability to repair…
Astrocytes, a type of support cell in the brain, showed metabolic defects and unusual pro-inflammatory activity that likely contributes to…
The European Commission is expected to propose a new governing framework for health data next month, called the European Health…
The U.S. Department of Defense (DoD) is offering grant awards to researchers working to improve care for Friedreich’s ataxia.
Targeting the end regions of FXN mRNA – the intermediary molecule used to make frataxin – may allow cells to…
A team of scientists at Koc University in Turkey has created three new cell models of Friedreich’s ataxia (FA)…